Human Neuropilin-2 PharmaGenie ELISA Kit (SBRS0944)

Neuropilin-2 quantitation in human samples is enabled by this Assay Genie PharmaGenie ELISA kit, built to support researchers investigating tumor lymphangiogenesis, VEGF/semaphorin signaling pathways, and immune cell trafficking.

The 96-assay configuration provides an absorbance-based readout compatible with standard microplate readers, with protocols validated for human plasma samples, human serum samples, and cell culture supernatant preparations.

NRP2, the target transmembrane glycoprotein, acts as a co-receptor in pathways governing metastatic spread, vascular patterning, and axon guidance, making this kit a useful reagent for oncology, vascular biology, and neuroscience laboratories.

The kit supports longitudinal biomarker studies and disease model characterization where expression dynamics of this VEGF-C/D binding partner inform therapeutic research. Each kit ships with components formatted for reproducible measurements across experimental runs, intended for research use only.